Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

  1. Khushalani, N.I.
  2. Ott, P.A.
  3. Ferris, R.L.
  4. Cascone, T.
  5. Schadendorf, D.
  6. Le, D.T.
  7. Sharma, M.R.
  8. Barlesi, F.
  9. Sharfman, W.
  10. Luke, J.J.
  11. Melero, I.
  12. Lathers, D.
  13. Neely, J.
  14. Suryawanshi, S.
  15. Sanyal, A.
  16. Holloway, J.L.
  17. Suryawanshi, R.
  18. Ely, S.
  19. Segal, N.H.
Aldizkaria:
Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426

Argitalpen urtea: 2024

Alea: 12

Zenbakia: 3

Mota: Artikulua

DOI: 10.1136/JITC-2023-007364 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus